MEG - CNBC

search results for

refine results

sort by

Date
Relevance

result type

Articles
Video

Wires
Press Releases

Debugging the Zika threat

CNBC's Meg Tirrell discusses Google's efforts to stop the Zika virus.

Source: CNBC.com

Scientists fighting mosquito-borne disease using sterilization bacteria

CNBC's Meg Tirrell reports on efforts to battle mosquito-related diseases, like Zika, in new trials being tested in Key West, Florida.

Source: CNBC.com

Vertex shares soar on positive cystic fibrosis trials

CNBC's Meg Tirrell reports Vertex's drug trials for cystic fibrosis were better than the Street expected.

Source: CNBC.com

Vertex Pharma’s three-drug combinations improve breathing in some cystic fibrosis patients

Vertex is attempting to expand treatment options to about 40 percent of cystic fibrosis patients.

Source: CNBC.com

Vertex soars after drug trial results

CNBC's Meg Tirrell reports that Vertex's cystic firbrosis drugs improve lung function and shares are popping after hours.

Source: CNBC.com

Vertex reports results from 3-drug cystic fibrosis combos

CNBC's Meg Tirrell reports on Vertex reporting results from its 3-drug cystic fibrosis combinations.

Source: CNBC.com

Projected cost for Puma breast cancer drug up to $10,000

CNBC's Meg Tirrell reports on a jump in shares of Puma after the FDA approves a drug for breast cancer and the projected costs of the drug.

Source: CNBC.com

FDA moves to increase generic competition

President Donald Trump has continually returned to two major themes when it comes to the pharmaceutical industry.

Source: CNBC.com

Johnson & Johnson reports mixed second quarter, revenues shy of expectations

CNBC's Meg Tirrell report Johnson & Johnson kicks off health-care earnings with an EPS beat of $1.83 adj on revenues of $18.839 billion.

Source: CNBC.com

Puma reopens after FDA approval for breast cancer drug

CNBC's Meg Tirrell reports on Puma moving higher after hours after the FDA approves their breast cancer drug.

Source: CNBC.com